Guest guest Posted January 4, 2001 Report Share Posted January 4, 2001 DoD press briefing when the AVIP was announced, 15 Dec 1997 -- " problems found were not in the anthrax production line " : On the day the AVIP policy was announced a general or flag officer who declined to be named made the following false statement about the FDA's March 1997 Notice of Intent to Revoke the anthrax vaccine manufacturer's license: " Last spring the Food and Drug Administration notified the producer of the vaccine -- the Michigan Biological Laboratory -- that they had some production problems with regard to quality assurance and production practices and they needed to fix these. Those were identified, a management plan was put in place, we worked closely with the lab to do that. The problems found were not in the anthrax production line, they were in other areas of other products being produced in the lab. " (See: http://www.defenselink.mil/news/Dec1997/x12181997_x1215mfp.html) DoD press briefing, 5 Aug 1999 -- another anonymous general made the following statement: " The first [issue] that's sort of hanging in the background and I think needs a direct answer is the FDA having to shut the plant down for renovations. That's another one of those urban legends or something that just keeps cropping up. We planned to shut the plant down to modernize it... " ( See: http://www.defenselink.mil/news/Aug1999/x08051999_x0805ant.htm) Fact: The statements above infer the closure of the anthrax vaccine manufacturing facility was due to " renovations " , rather than the real reason -- multiple failures of FDA inspections leading to the FDA to conclude in a 20 Feb 1998 report finding: " The anthrax vaccine manufacturing process is not validated. " Major L. " Buzz " Rempfer Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.